Iron dyshomeostasis and mitochondrial impairments are both vitally important for the progression of many neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Nevertheless, how these two pathological phenomena are linked with one another remains unclear, especially in neurons. To address the question, a model of iron overload was established with exposure of rat primary cortical neurons to excessive iron. We first verified that iron overload resulted in a decrease in adenosine triphosphate (ATP) production in neurons. Meanwhile, the release of mitochondrial cytochrome c was significantly increased after iron overload and consequently triggered an apoptosis signal, as revealed by Caspase 3 cleavage. To explore the potential underlying molecular mechanisms, an unlabeled quantitative proteomics approach was applied to primary neurons. Gene Ontology enrichment analysis revealed that 58 mitochondria-associated proteins were significantly altered, including three subunits of mitochondrial complex I and optic atrophy 1(OPA1). Increased NADH-ubiquinone oxidoreductase 75 kDa subunit and decreased NADH-ubiquinone oxidoreductase subunit A10 levels were further validated by a western blot, and more importantly, complex I activity markedly declined. Iron-induced down-regulation on the OPA1 level was also validated by a western blot, which was not reversed by the anti-oxidant but was reversed by the iron chelator. Moreover, an OPA1-associated key downstream effect, mitochondrial fragmentation, was found to be aggravated in neurons exposed to excessive iron, which is consistent with the down-regulation of OPA1. Furthermore, the protein level of PTEN-induced putative kinase 1, an important protein closely related to complex I activity and mitochondrial fragmentation, also significantly declined in neurons by iron overload. Thus, our findings may shed new light on the linkage between iron toxicity and mitochondrial impairments, such as energy supply deficiency and mitochondrial fragmentation, and further expand the toxic repertoire of iron in the central nerve system.
neurodegenerative diseases (NDs), including Alzheimer's disease (AD) and Parkinson's disease (PD) (Zecca et al. 2004; Ke and Qian 2007) . By means of high-resolution magnetic resonance imaging, elevated brain iron deposition was observed in AD and PD patients and animal models (Gorell et al. 1995; Nielsen et al. 1995; Vanhoutte et al. 2005; El Tannir El Tayara et al. 2006; Zhu et al. 2009; Haller et al. 2010; Penke et al. 2012) . Meanwhile, a great number of studies suggest that excessive liable iron in the brain can induce severe neurodegeneration and raise the risk of AD (Bartzokis et al. 2004 (Bartzokis et al. , 2007 Lehmann et al. 2006; Keogh et al. 2012) . On the other hand, many iron chelators and natural products with iron chelating abilities show promising neuroprotective effects against PD and AD ( Kaur et al. 2003; Ritchie et al. 2003; Youdim et al. 2004; Dexter et al. 2011; Kupershmidt et al. 2012; Prasanthi et al. 2012) . Thus, the iron dyshomeostasis hypothesis is considered as one of the main pathogenesis of NDs and is drawing more and more attention.
Accumulating evidence suggests that iron plays a critically role in mitochondrial function in the central nervous system. Firstly, the brain is a high-rate metabolic organ, consuming about one-fifth of the oxygen and energy of the whole body, and both oxygen consumption and energy production require iron and mainly take place in the mitochondria. As a matter of fact, mitochondria are intracellular iron pools that form iron sulfur clusters, which are essential for processes such as respiratory chain, oxidative phosphorylation, gene expression, oxygen sensing, and DNA damage recognition and repair (Horowitz and Greenamyre 2010; Gille and Reichmann 2011; Beilschmidt and Puccio 2014) . Secondly, it has been widely accepted that mitochondrial dysfunction is an important hallmark in NDs (Hirai et al. 2001; Rugarli and Langer 2012; Grimm and Eckert 2017) , which is closely associated with iron dyshomeostasis in neurodegeneration models (Kotzbauer et al. 2005; Gille and Reichmann 2011; Santambrogio et al. 2015) . Recently, a mitochondria-targeted iron chelator showed promising protective effects against neuronal injuries, indicating a key role of mitochondria in the process of iron induced neurodegeneration (Mena et al. 2015a) . In fact, the coexistence of both reactive oxygen species and iron in the mitochondria makes it particularly vulnerable to oxidative stress (Mena et al. 2015b) . However, the involvement of other regulative mechanisms of iron dyshomeostasis on mitochondrial dysfunction remains to be clarified.
All types of brain cells are equipped with iron metabolism proteins, but their responses to iron toxicity are quite different. A few in vitro studies indicate that excessive iron causes severe injury in primary neurons, whereas most of glia, especially astrocytes, are hardly affected (Regan and Panter 1993; Kress et al. 2002; Jaremko et al. 2010) . Moreover, in an iron overload rat model, large numbers of neurons are lost, which leads to neurotransmitters inadequacy (Ma et al. 2012) . Taken together, neurons are more vulnerable to iron toxicity, and may take a greater responsibility in iron-involved neurodegeneration. Still, the question of how iron influences the mitochondrial function in neurons remains unsolved.
To address the above questions, a model of iron overload was applied to primary rat cortical neurons. Neuronal mitochondrial features including energy supply and apoptotic changes were evaluated. By means of a label-free quantitative proteomic approach, a large group of mitochondriaassociated proteins were revealed to be influenced. Mitochondrial complex I activity as well as mitochondrial fragmentation were evaluated in neurons based on the clues from the proteomic study.
Materials and methods

Materials and preparation
Ferric ammonium citrate (FAC), deferoxamine (DFO), and N-acetylcysteine (L-NAC) were dissolved with deionized water to 10-100 mM, and carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was dissolved with dimethyl sulfoxide to 100 mM as a stock solution. The stock solutions were all kept at À20°C until usage. The antibodies used in this study were rabbit anti-optic atrophy 1 (OPA1, ARP57715_P050, 1 : 1000; Aviva, San Diego, CA, USA), mouse anti-NADH-ubiquinone oxidoreductase 75 kDa subunit [Ndufs1, AB52690, research resource identifiers (RRID): AB_2151096, 1 : 500; Abcam, Cambridge, UK], mouse anti-NADH-ubiquinone oxidoreductase subunit A9 (NDUFA9, AB14713, RRID: AB_301431, 1 : 1000; Abcam), rabbit anti-NADH-ubiquinone oxidoreductase subunit A10 (NDUFA10, AB96464, RRID: AB_10680370, 1 : 3000; Abcam), rabbit anti-PTEN-induced putative kinase 1 (PINK1, AB23707, RRID: AB_447627, 1 : 1000; Abcam), mouse anti-Parkin (P6248, RRID: AB_477384, 1 : 3000; Sigma, St Louis, MO, USA), rabbit anticytochrome c (556433, RRID: AB_396417, 1 : 500; BD, San Jose, CA, USA), rabbit anti-Caspase 3 (9661s, RRID: AB_2341188, 1 : 500 for cleaved Caspase 3, 1 : 3000 for Caspase 3; CST, Danvers, MA, USA), and mouse anti-b-actin (A5441, RRID: AB_476744, 1 : 20 000; Sigma). Validation data for the antibodies are available from the respective companies. Unless otherwise stated, all of the other chemicals were purchased from Sigma.
Primary cortical neuron culture and treatment
The primary cortical neurons were cultured as previously described (Zhang et al. 2013) . In brief, the female pregnant Sprague-Dawley (SD, RRID: RGD_734476, E16-E17, n = 50) rats were deeply anesthetized with an overdose of chloral hydrate (0.5 g/kg) to minimize animal suffering, and the cortices of rat embryos (n = 8-12 each experiment) were dissected in cold Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, Carlsbad, CA, USA), dissociated with 0.125% (w/v) trypsin (Invitrogen) at 37°C for 15 min and then triturated with a pipette in DMEM with 10% (v/v) fetal bovine serum (Invitrogen). The supernatants were collected and filtered through a strainer (300/400 mesh). Then, the cell suspension was diluted into its optimal concentration by DMEM with 10% fetal bovine serum and transferred onto poly-L-lysine (Sangon Biotech, Shanghai, China) coated plates. Four hours later, the culture medium was replaced with neurobasal medium (Invitrogen) with 0.5 mM L-glutamine, 2% (v/v) B27 supplement, penicillin (60 mg/L) and streptomycin (50 mg/L).
Half of the culture medium was refreshed every 3 days. After 9 days in vitro, the neurons were treated with FAC (30-300 lM), FeCl 3 (100 lM), DFO (100-300 lM), and/or L-NAC (100-300 lM) for 24 h, while CCCP (10 lM) treatment was performed 2 h before the cell culture termination at day 10 in vitro. The purity of primary cultured neurons was assessed by an immunocytochemical technique using Tau as neuronal marker and glial fibrillary acidic protein (GFAP) as a glial protein marker (data not shown). The SD rats used in this study were obtained from Shanghai SLACCAS Laboratory Animal Company (Certificate No.: SCXK (Hu) 2017-0005) and maintained in the specific pathogen-free and Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) approved animal facility. The primary neurons and glia culture protocol was approved by the Institutional Animal Care and Use Committee (protocol#2016-03-ZHY-74) of Shanghai Institute of Meteria Medica.
Detection of mitochondrial ATP production
The ATP production of primary cortical neurons was measured using a bioluminescent ATP detection kit (Promega, Madison, WI, USA). In brief, 24 h after each treatment, the primary cortical neurons were incubated with an equal volume working buffer containing luciferin substrate and luciferase enzyme, and the solution was shaken for 2 min at about 20-22°C. After resting for 10 min, the bioluminescence was assessed on a multimode detector (DTX800; Beckman Coulter, Atlanta, GA USA). The ATP level was calculated and normalized by a control group.
Measurement of intracellular ROS
Reactive oxygen species (ROS) generation was measured by a 2 0 ,7 0 -dichlorofluorescein (DCF) probe assay. Twenty-four hours after each treatments the cells in the black 96-well plates were incubated with 10 lM 2 0 ,7 0 -dichlorofluorescein diacetate (H2DCF-diacetate; Molecular Probes, Eugene, OR, USA) at 37°C in the dark for 45 min. The DCF intensities were quantified using a multimode detector (DTX800; Beckman) with 485-nm excitation and 520-nm emission filters. The fluorescence intensities were normalized to the control group.
Subcellular cytochrome c detection
To detect cytochrome c in cytosol and mitochondria enriched fractions, a Cell Fractionation kit (ab109719, Abcam) was used. In brief, after each treatment, the harvested primary neurons went through sequential and selective detergent-extraction to avoid a mechanical disruption of cells, so that most of the mitochondria could remain intact until Detergent II was applied. Then, the two subcellular enriched fractions were mixed with a 59 SDS loading buffer and loaded onto a sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Protein extraction and western blot analysis After each treatment, the primary cortical neurons were lysed on ice with a radio immunoprecipitation assay (RIPA) (50 mM Tris, 150 mM NaCl, 2 mM EDTA, 1 mM NaF, 1 mM sodium vandate, 1 mM phenylmethylsulfonyl fluoride, 1% Triton, 0.1% SDS, 0.5% sodium deoxycholate, 1% P8340 protease inhibitors cocktail, pH 7.4) for 30 min. After being centrifuged at 12 000 g for 15 min at 4°C, the supernatant was collected, and the total protein content was determined by a bicinchoninic acid protein After each band was normalized to its loading control, the ratio to the control group was calculated.
Centrifugal proteomic reactor
Twenty-four hours after each treatment, the primary cortical neurons (six biological replicates of both controls, and FAC samples) were washed three times with ice-cold phosphate-buffered saline and harvested in the lysis buffer (8 M urea, 4% CHAPS, 50 mM NH 4 HCO 3 , with protease inhibitors). The final protein concentration was determined by the Bradford method. Then the extracted proteins were processed by a centrifugal proteomic reactor (Zhou et al. 2011) . In brief, 20 lg of protein from each sample was acidified by 1% formic acid, and then mixed with a strong cation exchange slurry, followed by centrifuged and washed by 0.5% formic acid. After reduction and alkylation by dithiothreitol and iodoacetamide, the resulting pellet was dissolved in 1 M NH 4 HCO 3 and digested by trypsin (Promega). Finally, the digested peptides were eluted and subjected to a liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis.
LC-MS/MS
The LC-MS/MS was performed as previously described with some modifications (Chen et al. 2015) . In brief, samples were acidified with formic acid to a final concentration of 0.1% (v/v) and loaded on a 75 lm 9 150 mm fused silica column packed in-house with 3-lm ReproSil-Pur C18 beads (120 A; Dr. Maisch GmbH, Ammerbuch, Germany) using an Easy nano-UPLC 1000 (Thermo Electron, Waltham, MA, USA). The peptides were eluted using a gradient (5-80% acetonitrile with 0.1% formic acid) at a flow rate of 300 nL/ min over 240 min period into a nano-ESI Velos Pro-Orbitrap Elite mass spectrometer (Thermo Electron). The mass spectrometer was operated in data-dependent mode with each full MS scan, followed by MS/MS for the 10 most intense ions with the following parameters: ≥ +2 precursor ion charge, 2 Da precursor ion isolation window, and 35% normalized higher-energy collisional dissociation (HCD) collision energy. A full MS scan was collected for peptides from 400 to 2000 m/z on the Orbitrap analyzer at a resolution of 60 000 (at m/z = 400), and the subsequent MS/MS analyses were performed in the same analyzer at a resolution of 15 000 (at m/ z = 400).
LC-MS/MS data analysis
Maxquant (version 1.3.0.5) was used for database searching (Cox and Mann 2008) . Carbamidomethyl (C) was set as a fixed modification, and oxidation (M, +15.99492 Da) was set as a variable modification. The peak list generated was searched against the decoyed rat International Protein Index protein sequence database (version 3.87; European Bioinformatics Institute) augmented with the reversed sequence of each entry in the forward database with the initial precursor and fragment mass tolerance set to 6 and 20 ppm respectively. Trypsin/P was selected as the digestive enzyme with two potential missed cleavages. Only fully tryptic peptides ranked first were accepted in our database searching results. The false discovery rate of peptides and proteins was controlled at < 1% by the Andromeda search engine. Label-free quantification was carried out using intensity determination and normalization algorithm. Then, the peptide intensity and protein label-free quantification (LFQ) intensity lists of the 12 samples were further processed using Perseus software (version 1.2.0.16). The LFQ intensity values were logarithmized (Log2), and the missing value was inputed with random numbers from a normal distribution (width = 0.3, shift = 1.8). The p-value of the protein between two cohorts was calculated using the limma package in R/Bioconductor, and p < 0.05 was set as the significance criteria.
Complex I activity assay
The activity of complex I (NADH dehydrogenase, E.C. 1.6.5.3) in the primary cortical neurons was measured with a kinetic colorimetric microplate assay kit (ab109721; Abcam) according to the manufacturer's instructions. In brief, 24 h after each treatment, the primary cortical neurons from each group were determined by a bicinchoninic acid assay and diluted to the same protein amount. After preparing the extracts from neurons, the samples were loaded into pre-coated antibody capture wells in a microplate. After incubating for 3 h at about 20-22°C, each well was washed with 19 wash buffer twice. Once the assay solution, which contained NADH and dye, was added, place the microplate in a multimode detector (DTX800; Beckman). The OD was recorded at 450 nm for 30 min with 30-s intervals. The activity of complex I was represented as DmOD/min.
Evaluation of mitochondrial morphology
For observing the mitochondrial morphology, a primary cortical neuron-glia co-culture technique was applied to MitoTracker staining experiment. In brief, primary glial cells were raised in DMEM/F12 and seeded into a poly-L-lysine coated cell insert chamber (Millipore). On the next day, the primary cortical neurons were prepared as previously described and seeded into a glass bottom plate (In Vitro Scientific, Mountain View, CA, USA) with primary glia cultured in a hanging chamber. The media refreshment and treatment of co-culture cells was the same as in the primary neurons. After each treatment, the primary cortical neurons were incubated with MitoTracker Deep Red probe (250 nM; Invitrogen) for 45 min under growth condition. After three washes with D-phosphate-buffered saline, the neurons were fixed with 4% paraformaldehyde for 15 min at about 20-22°C. Cell nuclei were stained by 4,6-diamidino-2-phenylindole dihydrochloride (1 lg/mL; Roche Molecular Biochemicals, Indianapolis, IN, USA). The mitochondrial morphology was visualized by a confocal laser scanning microscopy (FV1000; Olympus, Tokyo, Japan). To quantify parameters of mitochondrial morphology, an ImageJ macro (Mito-Morphology Macro) was employed as described previously (Dagda et al. 2009 ). In brief, after selecting the area of each neuron, the red channel of stained neurons was inverted to show mitochondria-specific fluorescence as black pixels. The circularity, number and total area of the mitochondria were calculated by ImageJ with the Mito-Morphology macro. The inverse circularity was used as an index of mitochondrial elongation. 
Statistical analysis
Results
Iron overload reduced energy supply Mitochondria are vital to cells because of their role as neuronal energy suppliers. On the other hand, mitochondria play a detrimental role as cellular apoptosis regulators. We measured mitochondrial function of both aspects in a neuronal iron overload model, in which FAC was used as a source of free ferric ion. After a 24-h treatment of FAC, the neuronal ATP production declined significantly in a dose-dependent manner (30 lM: 95.6 AE 1.4%; 100 lM: 92.0 AE 1.9%; 300 lM: 86.0 AE 1.5%), and DFO, an iron chelator, exhibited an inverse tendency (100 lM: 97.0 AE 1.6%, 300 lM: 92.2 AE 2.5%) (Fig. 1a) . ROS generation, a byproduct with mitochondria, was also measured by the DCF probe in primary cortical neurons. After a 24-h treatment, FAC significantly increased the ROS level (178.7 AE 6.0%), which was blocked by L-NAC (136.7 AE 8.5%), a free radial scavenger ( Figure. 1b).
Iron overload triggered mitochondria involved apoptosis Then, apoptosis was assessed in cortical neurons after iron overload. We separated mitochondria and cytosol using a cell fractionation kit and examined the cytochrome c content in the two fractions. As shown in Fig. 2(a) , FAC significantly decreased cytochrome c in the mitochondrial enriched fraction (0.7 AE 0.1), which synchronized with the increase of cytochrome c in the cytosolic fraction (8.0 AE 2.8), compared to that in the control group. Here, CCCP, a chemical inhibitor of oxidative phosphorylation, was used as a positive control to induce cytochrome c mobilization from mitochondria to cytosol (Gottlieb et al. 2003) . The protonophore CCCP was applied 2 h before cortical neurons lysis and cytochrome c release was observed as expected (mitochondrial: 0.5 AE 0.2, cytosolic: 9.7 AE 3.0). Caspase 3 is the executive protein for mitochondria involved apoptosis pathway, which is activated after cleavage (Liu et al. 1996) . The FAC treatment markedly raised the level of cleaved Caspase 3 in a dose-dependent manner (30 lM: 117.7 AE 20.3%; 100 lM: 175.6 AE 17.8%; 300 lM: 197.5 AE 28.0%), while the iron chelator DFO almost fully blocked the cleavage (100 lM: 115.3 AE 18.4%; 300 lM: 89.3 AE 16.7%) (Fig. 2b) . L-NAC was applied together with FAC to diminish the intracellular oxidative effects of iron in primary cortical neurons. According to our results, cleavage induced by iron overload on Caspase-3 was not significantly influenced by a L-NAC treatment (Fig. 2c) Alteration of a large group of mitochondrial proteins by iron overload To investigate the molecular mechanism, the resulting protein extracts from the primary cortical neuron cultures were analyzed using a label-free quantitative proteomic workflow (Fig. 3a) . The consistency and reproducibility of this proteomic platform have already been demonstrated in our previous studies (Chen et al. 2015) . In the present study, the peptide and protein data filtration were based on stringent criteria of < 1% false discovery rate for both peptide and protein group levels, providing highly confident protein identification. As shown in As shown in Fig. 3(b) , a box plot was generated to compare the LFQ intensity of each protein across all 12 individual samples. The mean of Log 2 LFQ intensity (~21.23 AE 0.03 for each sample) is almost at the same level across all of the samples, which indicates that the LFQ analysis have no biases toward different samples. As shown in Fig. 3(c) , the correlation co-efficient of the LFQ intensity between two LC-MS/MS runs was higher than 0.90. Relative label-free quantitation profiling was highly reproducible between two LC-MS/MS runs intra each cohort or inter two cohorts. The protein-level volcano plots of log 2 ratio and the p-value between the control and the FAC-treatment groups are shown in Fig. 3(d) , and they are very similar to the normal distribution, which indicates that our experimental procedures were performed without any bias toward different samples. Furthermore, Student's t-test analyses were performed to identify differentially expressed proteins between the control and FAC treatment group. Iron related proteins were listed in Fig. 3 (e) (p < 0.05). Consistent with previous studies, hemeoxygenase 1 (Hemdan and Almazan 2006), ferritin heavy chain 1, ferritin light chain 1, and b-amyloid precursor protein had significantly increased (Aziz and Munro 1987; Hentze et al. 1987; Rogers et al. 2002) , while levels of transferrin receptor protein 1 decreased in the FAC-treatment group in our study (Koeller et al. 1989) (Fig. 3e) . These results further validated the quality of the MS-based proteomic assessment and the successful establishment of the iron overload cellular model.
To further investigate how iron overload influences mitochondria, we performed a Gene Ontology (GO) categorization analysis using DAVID Bioinformatics Resources (https://david.ncifcrf.gov/) ( Figure S1 ). We focused on the mitochondrial proteins from the cellular component category results of GO annotation. There were 58 significantly changed mitochondrial proteins in the iron overload group, with 25 proteins up-regulated and 33 proteins downregulated ( Table 1) . As documented in the Human Protein Atlas database, 21 different proteins were discovered to be mainly localized in the mitochondria (marked by 'a' in Table 1 ). Next, some energy supply and apoptosis related proteins were chosen for further study. Iron overload impaired mitochondrial complex I According to a proteomic analysis, three subunits of mitochondrial complex I, Ndufs1, NDUFA10 and NDUFA9 were significantly altered with a FAC/Con ratios of 1.19, 0.74, and 1.3 respectively (Fig. 4a-c) . Employing a western blot analysis, Ndufs1 and NDUFA10 were further confirmed to be significantly up-(138.6 AE 15.4%) and down-regulated (74.3 AE 5.8%) by iron overload (Fig. 4d and e) , respectively, but not NDUFA9 (Fig. 4f) . Additionally, DFO could almost diminish the alteration on Ndufs1 (111.6 AE 9.287%) and NDUFA10 (84.0 AE 8.8%). FeCl 3 , another form of ferric ion, was also able to change Ndufs1 ( Figure S2a ) and NDUFA10 expression ( Figure S2b ). Considering reduced mitochondrial energy supply and the abnormal expression of complex I subunits in iron overload neurons, we asked whether the activity of complex I was influenced. Interestingly, FAC significantly reduced neuronal complex I activity (con: 1.1 AE 0.13; FAC 100 lM: 0.76 AE 0.083), which could be partially inhibited by DFO (0.98 AE 0.18).
Iron overload reduced OPA1 expression OPA1 plays key roles in both cristae integrity maintenance and apoptotic signaling (Olichon et al. 2003) . As shown in Fig. 5(a) 's box plot, OPA1 was significantly changed with a FAC/Con ratio of 0.86 and a p-value of 2.17E-2 in neurons.
To verify the alteration emerging from LFQ, a western blot was performed on this protein. As shown in Fig. 5(b) , FAC treatment markedly reduced the expression of OPA1 in a dose-dependent manner (100 lM: 78.0 AE 4.6%; 300 lM: 61.5 AE 3.8%), which could be almost blocked by DFO (100 lM: 124.1 AE 12.3%; 300 lM: 99.7 AE 9.3%) (Fig. 5b) . CCCP, which had been reported to induce the proteolytic cleavage of OPA1, reduced OPA1 levels remarkably (41.0 AE 16.1%), implying that the bands detected approximately 120 kDa were full length OPA1. FeCl 3 was also able to decrease OPA1 expression ( Figure S2c) . To assess the influence of iron's oxidation capability on OPA1 expression, L-NAC was applied to iron overload neurons. Interestingly, L-NAC treatment barely impacted the downregulation of OPA1 caused by iron overload (Fig. 5c) Iron overload induced mitochondria fragmentation Mitochondria are dynamic organelles and the balance of fission-fusion sustains mitochondrial quality control. OPA1 is a dynamin-related GTPase and also in charge of cristae remodeling during mitochondrial fusion (Cipolat et al. 2004) . To determine the relevance between iron-induced OPA1 down-regulation and mitochondrial fusion, an unbiased custom macro for NIH ImageJ was applied. As shown in Fig. 6(a) , most of the control neurons displayed normal, tubular mitochondria through confocal microscopy observation. Under FAC treatment at 100 lM, the mitochondria of neurons turned much shorter than that of the control group. CCCP was used as positive control treatment to cause mitochondrial fragmentation, and punctiform mitochondria were observed in almost all of the CCCP treated neurons. Consistent with the appearance changes, the mitochondrial elongation scores significantly decreased in FAC (6.9 AE 0.3 vs. control 7.9 AE 0.3) and CCCP (5.5 AE 0.4) groups (Fig. 6b) . At the same time, the mitochondria numbers per neuron and total area of mitochondria both reduced markedly after FAC treatment (number: 41.5 AE 2.9 vs. control 64.4 AE 4.3; area: 140.0 AE 14.0 vs. control 257.3 AE 16.5) (Fig. 6c and d) . These changes in mitochondrial morphology and related parameters agreed with previous report in neurons of the OPA1 mutant, which prevented mitochondrial fusion (Wiemerslage and Lee 2016) . Hence, our data indicated that iron overload led to mitochondria fragmentation in neurons.
Iron overload reduced PINK1 expression PINK1 and Parkin are involved in mitochondria quality control. Their deficiency was reported to affect complex I and induce mitochondria fragmentation (Dagda et al. 2009; Lutz et al. 2009 ). Then, we evaluated their protein levels by a western blot and found that PINK1 was significantly reduced by FAC treatment (71.3 AE 6.7%), which could be totally reversed by iron chelation (102.1 AE 5.7%) (Fig. 7a) . In contrast, the protein level of Parkin was not altered (Fig. 7b) .
Discussion
Although iron homeostasis is important in mitochondria function and its disorder has been implicated in mitochondrial impairments in NDs (Gille and Reichmann 2011) , the way excess iron injures mitochondria function remains unclear. In this study, we systematically studied the mitochondria-associated proteins potentially involved in iron-induced mitochondrial impairments. The major impressive characteristics of the present study are the following: 1) mitochondrial complex I subunits, Ndufs1 and NDUFA10, were demonstrated to be significantly changed by iron overload and the activity of complex I was markedly declined, which may contribute to the deficiency of mitochondrial energy supply in neurons; 2) iron overload detrimentally down-regulated OPA1 expression, which may result in apoptosis signaling and mitochondria fragmentation; 3) PINK reduction induced by iron overload may be the link between the inhibition of complex I and poor mitochondria quality in NDs, especially PD.
Mitochondria has two opposite roles in cell metabolism. On the one hand, mitochondrial respiration and energy supply is vital to cell survival. Mitochondrial impairments, such as cristae integrity loss and mitochondrial Fig. 4 Iron overload misregulated subunits of mitochondrial complex I and inhibited its activity in primary cortical neurons. Label-free quantification intensity of Ndufs1 (a), NDUFA10 (b), and NDUFA9 (c) between control and FAC treatment. The levels of Ndufs1 (d), NDUFA10 (e), and NDUFA9 (f) were determined by western blot in primary cortical neurons treated with FAC and desferrioxamine (DFO) for 24 h. (g) The complex I activity was measured by a kinetic colorimetric microplate assay kit (Abcam, USA). The data are presented as the mean AE SEM (n = 5 independent experiments). ︒Indicates each data point. *p < 0.05 and **p < 0.01 versus control. Ndufs1, NADH-ubiquinone oxidoreductase 75 kDa subunit. fragmentation, will cause mitochondrial dysfunction. On the other hand, mitochondria play critical roles in the regulation of apoptosis through cytochrome c dependent caspase activation. Additionally, mitochondria are also important iron metabolism organelles where iron can be stored and utilized to form Fe-S cluster and heme. In this study, we find that iron overload caused a series of mitochondrial dysfunction in primary neurons and further triggered apoptotic signaling. Apoptosis induced by iron overload is often relevant to oxidative stress (Zhang et al. 2003; Kooncumchoo et al. 2006) , which is inseparable from mitochondrial respiration. However, the iron-induced apoptosis in our study is at least not totally because of oxidative damage, since the ROS increment caused by iron overloading was significantly reduced by an L-NAC treatment.
To provide novel clues on how iron overload influences mitochondria function, a proteomics approach is applied. As expected, a large group of mitochondria proteins are discovered to be significantly changed by iron overload. Among them, Ndufs1 and NDUFA10, subunits of mitochondria respiratory chain complex I, have been validated to be dysregulated in iron overloading neurons. Ndufs1 is the Fe-S cluster of complex I, so the accumulation of Ndufs1 may be because of a feedback of excess iron (Lin et al. 2001; Rouault and Tong 2005) . In our study, PINK1, another protein closely relevant to the function of complex I, has also been found to be significantly reduced by iron overload. Pathogenic mutations of PINK1 are causally important to PD. Both clinical mutations and loss-of-function mutations of PINK1 resulted in decreased complex I activity and deficient synaptic function (Morais et al. 2009 ). Moreover, it has been reported that the reduction in complex I activity and ATP synthesis in PINK1 loss-of-function mutations could be rescued by phosphomimetic NDUFA10, which is required for the ubiquinone binding of complex I (Morais et al. 2014) . Considering the decreased protein levels of NDUFA10, PINK1 deficiency may act upstream to NDUFA10 in iron overloading neurons, consequently leading to the decline of complex I activity and an energy supply deficiency. Therefore, our results, to our knowledge, may be the first to report that iron is able to inhibit complex I activity in neurons, which may be associated with the dysregulation of the subunits of complex I. Here, we find that cytochrome c is mobilized into cytoplasm, and, consequently, an apoptosis signal is triggered by caspase 3 cleavage. Among the group of mitochondria proteins screened by a mass spectrometric analysis, the decrease in OPA1 calls for attention. Because OPA1 is reported to be in charge of mitochondrial cristae remodeling, forming OPA1-containing complex and keeping cristae junction tightly to avoid leakage of content from the mitochondria intermembrane space out to the cytosol (Cipolat et al. 2006; Ramonet et al. 2013) . Depletion of OPA1 has already been reported to cause cytochrome c mobilization and trigger cell spontaneous apoptosis (Olichon et al. 2003; Lee et al. 2004) . Moreover, OPA1 has also been reported to be involved in the pathology of many types of NDs, including dominant optic atrophy, PD and AD Manczak et al. 2011; Lenaers et al. 2012; Carelli et al. 2015) . In our research, iron's downregulation of OPA1 is dose-dependent which can be thoroughly reversed by chelation. Meanwhile, the mRNA level of OPA1 does not alter significantly after a FAC treatment (data not shown). In addition to the ferric iron we used in this research, a ferrous treatment can also reduce full-length OPA1 expression in Hela cells (Baricault et al. 2007 ). However, the ferrous ion directly takes part in a Fenton reaction to generaten highly reactive hydroxyl radical. On the other hand, oxidative stimuli have been reported to cause OPA1 dismission from mitochondria in HT-22 neuroblastoma cells (Sanderson et al. 2015) . Through an L-NAC treatment to neutralize oxidation, we further prove that FAC down-regulation on OPA1 is probably not because of its iron oxidative capability. OPA1 cleavage has been identified to be regulated mainly by two metallopeptidases, OMA1 and m-AAA protease (Ehses et al. 2009; Head et al. 2009 ). As neither of them is changed significantly in protein levels after iron overload according to our proteomic analysis, it is possible that an iron treatment might influence enzyme activity. Further studies will be needed to confirm the possibility.
Mitochondria are dynamic organelles, constantly undergoing fission and fusion to facilitate the exchange of mitochondria contents such as mtDNA and to maintain mitochondria homeostasis and function. The mitochondria dynamic process is manipulated by several GTPases located on the mitochondrial outer and inner membrane, and OPA1 is the inner membrane GTPase facing the inter-membrane space and is in charge of inner membrane fusion (Olichon et al. 2002) . In our study, mitochondrial fragmentation is accompanied by iron induced OPA1 reduction, suggesting that the OPA1 functioning as fusion mediator is damaged as well. It has been reported that FAC triggers mitochondrial fragmentation via dephosphorylation on the fission mediator Drp1 protein in HT-22 cells (Park et al. 2015) . Taken together, it is suggested that iron overloading may induce mitochondria fragmentation through its influence on both the fusion and fission process.
Several similar phenomena have been reported under disease conditions. Clinically, a decreased expression of OPA1 has been found in brains of AD patients, correlating with impaired mitochondrial dynamics Manczak et al. 2011) . Similarly, OPA1 reduction and mitochondrial fragmentation is observed in AD-like amyloid precursor protein over-expression cells, whereas the over-expression of OPA1 can rescue mitochondria morphology alteration (Wang et al. 2008) . Moreover, two OPA1 missense mutations are recently reported to be related with parkinsonism and dementia. Fibroblast from these patients had less OPA1 protein with normal mRNA levels and fragmented mitochondria (Carelli et al. 2015) , which is similar with what we observed in iron overloaded neurons. Thus, our work indicates that an iron disorder may lead to a mitochondria dynamics impairment in NDs.
PINK1 and Parkin are two important proteins involved in mitochondria quality control. Usually, they work as ubiquitin kinase and E3 ubiquitin ligase in mitochondrial degradation. Loss of PINK1 has also been reported to induce mitochondria fragmentation (Dagda et al. 2009 ), Fig. 8 A hypothetical scheme for the mechanism of iron overload induced mitochondria dysfunction. Excessive iron treatment influenced a large group of mitochondrial proteins, including complex I subunits (Ndufs1 and NDUFA10) and OPA1. The increased Ndufs1 and decreased NDUFA10 may be associated with mitochondrial complex I activity decline and neuronal energy supply deficits. OPA1 deficiency may result in apoptosis initiation and mitochondrial fragmentation. Iron overload induced PINK1 reduction may act not only in complex I inhibition but also in mitochondrial fragmentation. Consequently, multiple mitochondrial impairments caused by iron overload lead to neuronal damage. Ndufs1, NADH-ubiquinone oxidoreductase 75 kDa subunit. which can be rescued by OPA1 expression or inactivation of Drp1 (Lutz et al. 2009 ). Here, we find that iron overload down-regulates not only OPA1 levels but also PINK1 levels, suggesting that OPA1 and PINK1 may both contribute to the process of iron-induced mitochondria fragmentation.
Energy supply
Conclusions
There are a few important implications of the present study (Fig. 8) . First, iron impacts a group of mitochondria associated proteins, suggesting that numerous mitochondrial functions may be affected. Second, changes of the Ndufs1, NDUFA10, and PINK1 protein levels are associated with decreasing complex I activity and neuronal energy supply deficits in iron overloading neurons. Third, the downregulation of OPA1 by iron overload is related to mitochondrial-involved apoptosis and mitochondrial fragmentation. Last but not least, iron overload induced PINK1 deficiency may link complex I inhibition with mitochondrial fragmentation. Taken together, the results suggest that mitochondria quality is impaired by iron overload. Hence, these findings expand the toxic repertoire of iron in central nervous system, with an implication of putative prevention and a treatment strategy in NDs.
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